Celldex Therapeutics
CLDX
#4208
Rank
C$4.26 B
Marketcap
C$54.35
Share price
-3.31%
Change (1 day)
79.32%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2026 (TTM): -C$0.43 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are C$0.86 Million. In 2025 the company made an earning of -C$0.4 Billion a decrease over its 2024 earnings that were of -C$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.43 Billion6.74%
2025 -C$0.4 Billion47.31%
2024 -C$0.28 Billion37.34%
2023 -C$0.2 Billion32.63%
2022 -C$0.15 Billion54.88%
2021 -C$96.07 Million39.49%
2020 -C$68.87 Million-9.08%
2019 -C$75.75 Million-28.64%
2018 -C$0.11 Billion-30.11%
2017 -C$0.16 Billion-17.75%
2016 -C$0.19 Billion4.5%
2015 -C$0.18 Billion4.09%
2014 -C$0.17 Billion51.57%
2013 -C$0.12 Billion40.1%
2012 -C$79.95 Million
2010 -C$1.74 Million-96.59%
2009 -C$50.85 Million
2006 -C$31.08 Million
2004 -C$18.87 Million15.75%
2003 -C$16.31 Million-18.69%
2002 -C$20.05 Million-41.22%
2001 -C$34.11 Million59%
2000 -C$21.46 Million27.65%
1999 -C$16.81 Million53.12%
1998 -C$10.98 Million2.6%
1997 -C$10.7 Million-33.62%
1996 -C$16.12 Million-1.69%
1995 -C$16.4 Million22.92%
1994 -C$13.34 Million-0%
1993 -C$13.34 Million
1991 -C$8.2 Million90.32%
1990 -C$4.31 Million10.71%
1989 -C$3.89 Million833.33%
1988 -C$0.42 Million-400%
1987 C$0.13 M-125%
1986 -C$0.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.71 B-3,526.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.62 B-3,040.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.90 B-3,339.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-C$3.9 Million-99.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-C$1.1 Billion 155.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.16 B-138.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$82.1 M-119.12%๐Ÿ‡บ๐Ÿ‡ธ USA